Clik here to view.
4 Key Insights When Raising Money for Your Medtech Startup: Interview with...
Welcome to the Medsider interview series, a regular feature at MassDevice. All interviews are conducted by Scott Nelson, Founder of Medsider and Group Director for WCG. We hope you enjoy them! Bruce...
View ArticleClik here to view.
Viveve Medical reports success treating vaginal laxity
Viveve Medical recently published the results of a clinical study of its Viveve I treatment in the Journal of Sexual Medicine, showing that women who received the treatment reported being more likely...
View ArticleClik here to view.
Philips wins FDA clearance for ElastQ liver imaging tech
Royal Philips (NYSE:PHG) said today that it won 510(k) clearance from the FDA for its ElastQ imaging technology, which allows for simultaneous imaging and assessment of tissue stiffness to diagnose...
View ArticleClik here to view.
Medtronic touts 5-year economic analysis data from CRT-focused Reverse study
Medtronic (NYSE:MDT) today released 5-year economic analysis data from its Reverse study of patients treated with cardiac resynchronization therapy devices, touting longer lifespans and long-term cost...
View ArticleClik here to view.
MedCrypt and QuiO partner to protect devices from cyberattacks
[Image courtesy of Blogtrepreneur on Flickr, per Creative Commons 2.0 license]MedCrypt and QuiO have announced an integration partnership for a set of cloud-connected injection devices known as the...
View ArticleClik here to view.
Mederi touts meta-study of Stretta GERD treatment device
Data from a meta-analysis study of Mederi Therapeutics Stretta device released this week indicate that treatments with the device reduced heartburn and improved health-related quality of life scores...
View ArticleClik here to view.
Orthofix shares steady on Q4, FY2016 Street-beating earnings release
Shares in Orthofix (NSDQ:OFIX) have stayed steady today after the medical device maker beat expectations from Wall Street with its 4th quarter and full fiscal year 2016 earnings results. The...
View ArticleClik here to view.
South African medical device companies have new licensing deadline
By Stewart Eisenhart, Emergo Group South Africa’s Medicines Control Council (MCC) has set a six-month deadline for domestic medical device and IVD manufacturers and distributors to apply for licensing...
View ArticleClik here to view.
Metallurgy firm exec cops to $75k bribe of Stryker engineer
An executive with a New York metallurgy firm, Sanova LLC, pleaded guilty yesterday to bribing an engineering director at Stryker (NYSE:SYK) to win a multi-million dollar contract, according to federal...
View ArticleClik here to view.
Boston Scientific gets in on $45m private placement for Corindus Vascular...
Boston Scientific (NYSE:BSX) got in on a $45 million private placement for Corindus Vascular Robotics (NYSE:CVRS) and the CorPath GRX device it’s developing for cardiac and peripheral vascular...
View ArticleClik here to view.
Elixir Medical’s DeSyne stent tops Medtronic’s Endeavor after 5 years
Elixir Medical‘s novolimus-eluting stent, DeSyne, outperformed Medtronic‘s (NYSE:MDT) zotarolimus-eluting stent, Endeavor, according to long-term data from Elixir’s Excella II trial. The study enrolled...
View ArticleClik here to view.
Motus GI raises $30m for Pure-Vu colonoscopy system
Motus GI said today that it closed a $30 million private placement which it plans to use in support of the commercial launch of its Pure-Vu colonoscopy system. The lead investor in the placement was...
View ArticleClik here to view.
TearLab readies for reverse split
Shares in TearLab Corp. (NSDQ:TEAR) said last week that its board approved a 1-for-1 reverse split of its common stock. The company’s shares have fallen nearly 20% since the beginning of the month. The...
View ArticleClik here to view.
Insulet slides on Q4 earnings miss
Insulet (NSDQ:PODD) shares are under pressure this morning after the diabetes company missed expectations for its 4th-quarter earnings, despite beating Wall Street’s consensus sales forecast....
View ArticleClik here to view.
FDA asks Titan for more info before clinical trial of ropinirole implant
Titan Pharmaceuticals (NSDQ:TTNP) said today that the FDA put a hold on the clinical trial of its ropinirole implant and told the company to submit more information to the federal watchdog. After it...
View ArticleClik here to view.
5 mistakes found in cloud-connected medical devices
Cloud-connected medical technology will have a significant impact on the healthcare system. Network-connected medical devices create a world of instant information, warns Dana Good senior software...
View ArticleClik here to view.
What is Good Clinical Practice?
Do you know why rules, regulations and standards exist? What exactly is Good Clinical Practice and how does this help protect patients and data integrity? Protecting patients is at the core of clinical...
View ArticleClik here to view.
Gamida Cell touts first patient treated in Phase III NiCord trial
Gamida Cell said today that the 1st patient has been treated in the Phase III registration trial of its NiCord cell graft for patients with blood cancer. The treatment is a graft derived from umbilical...
View ArticleClik here to view.
Globus shares dip on mixed-bag Q4, FY2016 earnings
Shares in Globus Medical (NYSE:GMED) have fallen slightly today after the medical device maker missed earnings per share expectations, but topped revenue with its 4th quarter and full fiscal year 2016...
View ArticleClik here to view.
MicroPort, undaunted by price caps, enters India’s stent market
MicroPort has entered the Indian market only days after the country’s National Pharmaceutical Pricing Authority imposed a price cap on coronary stents. The Shanghai-based company said its Firehawk...
View Article